Imeka Solutions

Sherbrooke, Quebec, Canada (with an office in Cambridge, Massachusetts, USA)  All Canada companies → Founded 2011
Imaging AI Specialist Specialty-Focused AI
Neurology Neurosurgery Radiology
Neurology AI Radiology & Imaging AI
Seed — $800K

Products

ANDI
Imeka Solutions
Neurology AI
ANDI is an advanced quantitative imaging software designed to enhance the evaluation of medical images, particularly in neuroimaging. Its core function revolves around processing diffusion-weighted images to map the microstructural properties of white matter in the brain.

See all 1 product →

About Imeka Solutions

Imeka Solutions is a leading healthcare AI company specializing in advanced neuroimaging, offering non-invasive solutions to quantify key markers of brain conditions. Their flagship clinical software, Advanced Neuro Diagnostic Imaging (ANDI), leverages artificial intelligence in conjunction with diffusion MRI to provide detailed analysis of brain white matter. ANDI has received FDA 510(k) clearance, making it a validated tool for neurologists and radiologists.

ANDI generates comprehensive reports that highlight white matter bundles deviating from normative ranges, offering in-depth microstructural and macrostructural values. This capability is crucial for the improved management of neurodegenerative diseases such as Alzheimer’s, Multiple Sclerosis, and Parkinson’s, by providing vital reference information on cerebral white matter. Beyond clinical applications, Imeka also supports pharmaceutical and biotechnology companies with its Advanced Neuro Imaging Endpoints platform, an AI-powered tool for white matter microstructure analysis to identify and quantify biomarkers like neuroinflammation, demyelination, and axonal loss, aiding in drug development and clinical trial monitoring.

Focus Areas

White matter imaging neuroinflammation axonal integrity myelin integrity brain connectivity neurodegenerative diseases Alzheimer's Disease Multiple Sclerosis Parkinson's Disease Traumatic Brain Injury diffusion MRI AI-powered diagnostics quantitative imaging software

Business Intelligence

Key InvestorsAlzheimer's Drug Discovery Foundation (ADDF), Canada's Scientific Research and Experimental Development tax credit program, Canada Economic Development for Quebec Regions (CED)
PartnershipsGE Healthcare, NervGen Pharma, IXICO, Philips, AMC Amsterdam, UMC Utrecht
TechnologyDiffusion MRI-based imaging combined with AI, advanced image-processing pipelines, machine-learning algorithms, Nextflow, PyTorch, cloud-native automated reporting. Products include Advanced Neuro Diagnostic Imaging (ANDI) system and ANIE biomarker platform.
FDA Clearances2 cleared products (estimated)

What Physicians Need to Know

White Matter Imaging Expertise
Imeka specializes in advanced white matter imaging, providing unmatched clarity and precision in analyzing microstructural properties of the brain's white matter. Their technology offers detailed insights into white matter health, including the ability to identify pathology in normal-appearing white matter.
Neuroinflammation Quantification
Imeka's ANIE biomarker platform is unique in its ability to identify and quantify neuroinflammation at the voxel level by assessing the free water fraction with remarkable sensitivity and specificity. This allows for precise measurement of inflammation, demyelination, and axonal degeneration.
Axonal & Myelin Integrity Assessment
The company provides detailed assessments of axonal and myelin integrity, crucial for understanding conditions like demyelination and axonal loss. Their software can identify the location, extent, and degree of demyelination and remyelination.
Brain Connectivity Analysis
Imeka's technology reconstructs the brain's fiber network, offering insights into white matter connectivity and the central nervous system morphology. Their ANIE platform extracts over 50 primary white matter fiber bundles, enabling unprecedented virtual dissection capabilities.
Neurodegenerative Disease Focus
Imeka's solutions are tailored for neurodegenerative diseases including Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease, and Traumatic Brain Injury, providing tools for better management and understanding of these conditions.
AI-Powered Diffusion MRI Diagnostics
They combine advanced diffusion MRI (dMRI) with artificial intelligence to analyze white matter MRI signals in greater detail than other techniques, facilitating AI-powered diagnostics and quantitative imaging.
FDA-Cleared Quantitative Imaging Software
Imeka offers FDA 510(k) cleared clinical software, ANDI (Advanced Neuro Diagnostic Imaging), which provides automated, quantitative analysis of brain white matter microstructural properties.
Physician Tip

Imeka Solutions offers physicians a powerful, non-invasive tool for detailed brain white matter analysis. The FDA-cleared ANDI software provides comprehensive, quantitative reports on neuroinflammation, axonal integrity, and myelin integrity, which can be crucial for early diagnosis, monitoring disease progression, and assessing therapeutic efficacy in neurodegenerative diseases like Alzheimer's, MS, Parkinson's, and TBI. The ability to identify subtle microstructural changes and quantify biomarkers at the voxel level, even in normal-appearing white matter, can significantly enhance clinical decision-making. Furthermore, the expected reimbursement through new CPT 3 codes for quantitative brain MRI assessment makes this advanced diagnostic more accessible for patient care.

Imeka's technology is built for seamless integration into clinical workflows, utilizing standard MRI machines for data acquisition. Their software solutions, including ANDI and ANIE, are designed to process diffusion-weighted images and generate DICOM-encapsulated PDF reports. The company has a history of strategic partnerships with pharmaceutical companies and has leveraged modern software development practices, including Nextflow for automated pipelines and PyTorch for AI model training, suggesting a robust and adaptable platform for various clinical and research environments.

Products by Imeka Solutions

1 product in the directory

ANDI
Imeka Solutions
Neurology AI
ANDI is an advanced quantitative imaging software designed to enhance the evaluation of medical images, particularly in neuroimaging. Its core function revolves around processing diffusion-weighted images to map the microstructural properties of white matter in the brain.

Reviews & Opinions

No web reviews on file yet for Imeka Solutions. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Imeka Solutions.

Loading videos...

Videos load interactively. If none appear, search YouTube for Imeka Solutions →

View all on YouTube

Press & Coverage

Imeka
ImekaTM receives FDA 510(k) clearance for ANDI 2.0
Imeka announced on November 1st, 2025, that its new and improved flagship software, ANDI 2.0, received FDA 510(k) clearance, adding brain volumetric analysis to its existing white matter microstructure mapping capabilities.
2025-11
BMC Neurology (PMC)
Rate of abnormalities in quantitative MR neuroimaging of persons with chronic traumatic brain injury
Published on July 5, 2024, this peer-reviewed article discusses the use of quantitative MR neuroimaging, including Imeka's FDA-approved Advanced Neuro Diagnostic Imaging (ANDI) tool, to detect abnormalities in individuals with chronic traumatic brain injury.
2024-07
PR Newswire
Imeka Receives Investment from Alzheimer's Drug Discovery Foundation for Biomarker Development
Imeka announced on October 24, 2023, an investment from the Alzheimer's Drug Discovery Foundation (ADDF) to accelerate the development of novel biomarkers for Alzheimer's disease and related dementias.
2023-10
PR Newswire
Imeka Receives FDA 510(k) Clearance for ANDI Medical Device
On July 31, 2023, Imeka announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its Advanced Neuro Diagnostic Imaging (ANDI) quantitative imaging software, which combines diffusion imaging and AI to map white matter microstructure.
2023-07
Applied Radiology
FDA Clears Imeka's Neuro Quantitative Imaging Software
Applied Radiology reported on August 1, 2023, that the FDA cleared Imeka's Advanced Neuro Diagnostic Imaging (ANDI) quantitative imaging software, designed to analyze microstructural properties of brain white matter.
2023-08
Fierce Biotech
Imeka's brain-mapping AI scores FDA clearance
Fierce Biotech covered the FDA 510(k) clearance of Imeka's AI-powered Advanced Neuro Diagnostic Imaging (ANDI) software on August 1, 2023, highlighting its ability to map brain white matter for conditions like Alzheimer's and multiple sclerosis.
2023-08
CNW Group (Government of Canada)
Government of Canada supports Imeka in marketing its new brain imaging tool ANDI
On July 25, 2023, the Government of Canada announced a repayable contribution of $250,000 for Imeka to support the marketing of its new medical brain imaging tool, ANDI (Advanced Neuro Diagnostic Imaging).
2023-07
PR Newswire
Imeka and GE Healthcare Collaborate to Advance Precision Medicine for Brain Health
Imeka announced a collaboration with GE Healthcare on April 5, 2022, to integrate Imeka's non-invasive neuroimaging technology into GE Healthcare's BrainWave advanced diffusion processing package.
2022-04

Frequently Asked Questions

Imeka Solutions combines advanced diffusion MRI (dMRI) with artificial intelligence (AI) to provide highly detailed and quantitative analysis of brain white matter. This technology allows for the precise mapping of microstructural properties, offering insights into neuroinflammation, axonal integrity, and myelin integrity that are crucial for understanding various brain conditions.
Imeka's technology is applied across a spectrum of neurodegenerative diseases and conditions, including Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease, and Traumatic Brain Injury. It aids in identifying specific biomarkers, monitoring disease progression, and evaluating the efficacy of treatments by quantifying changes in white matter.
Imeka offers the Advanced Neuro Diagnostic Imaging (ANDI) software, which is FDA 510(k) cleared for clinical use and provides comprehensive, automated white matter reports. For pharmaceutical and biotech research, they provide the Advanced Neuro Imaging Endpoints (ANIE) biomarker platform, designed to support clinical trial development and drug efficacy monitoring.
Yes, Imeka's ANDI software has received U.S. FDA 510(k) clearance, making it a regulated medical device in the USA. Furthermore, it is anticipated to be eligible for reimbursement starting in January 2024, following the introduction of new CPT 3 codes for quantitative brain MRI assessment.
Imeka offers comprehensive technical and administrative support services, accessible via a toll-free number and an online ticket system. They commit to a response time of within 4 hours for general requests and within 12 hours for advanced technical support during Eastern Time business hours.
Yes, Imeka has established significant partnerships, including a collaboration with GE Healthcare to integrate their neuroimaging technology into the BrainWave advanced diffusion processing package. They also partner with pharmaceutical companies like NervGen Pharma for clinical trials and have received investment from organizations such as the Alzheimer's Drug Discovery Foundation.
Founded in 2011, Imeka has over a decade of specialized experience in developing high-performance diffusion MRI pipelines, initially serving major pharmaceutical partners. The company has demonstrated consistent growth, secured investments, and is actively expanding its commercialization efforts for clinical applications.

Related Companies

Clarista is a healthcare AI company that focuses on building a “trust layer” for enterprise AI, particularly within regulated industries like healthcare and financial services. The company’s platform aims to address the challenges of data fragmentation, governance, and compliance that often hinder the successful implementation of AI projects in large organizations. Clarista’s technology unifies structured […]

HelloBooks.ai is an AI-powered accounting software company that aims to automate and simplify financial management for small businesses, freelancers, and accounting professionals. The platform utilizes generative AI to handle repetitive bookkeeping tasks such as transaction categorization, receipt capture, bank reconciliation, and report generation. It is designed to reduce manual data entry and improve accuracy, allowing […]

Vero, also known as Vero.ai, is an artificial intelligence company specifically designed to augment clinical workflows and improve patient care within the healthcare sector. Their primary focus is on leveraging AI to streamline administrative tasks, enhance diagnostic accuracy, and personalize treatment plans. By automating routine processes, Vero aims to free up healthcare professionals’ time, allowing […]

Ant Group, a global digital technology provider and operator of Alipay, has significantly expanded its focus into healthcare AI. The company recently upgraded its physician platform, Haodf for Doctor, into ‘AQ for Doctor,’ an AI-powered workstation designed to support physicians across various stages of clinical practice, including online consultations, patient management, clinical decision support, and […]

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.